James Marcucci
Cardiovascular Disease · Pittsburgh, PANPI 1801856034
Payments from drug & device makers
Across 176 payments — averaging $24.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$548
- Johnson & Johnson$535
- Pfizer$470
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$317
- Biotronik Inc.$315
- AstraZeneca$263
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,14297%
- Education$1133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 28 | $548 |
| Johnson & Johnson | 21 | $535 |
| Pfizer | 21 | $470 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $317 |
| Biotronik Inc. | 8 | $315 |
| AstraZeneca | 10 | $263 |
| Boston Scientific | 8 | $245 |
| Amgen | 11 | $224 |
| Astellas Pharma US Inc | 3 | $205 |
| E.r. Squibb & Sons, L.L.C. | 9 | $170 |
| United Therapeutics Corporation | 6 | $109 |
| Actelion Pharmaceuticals US, Inc. | 7 | $103 |
| Cvrx, Inc. | 3 | $101 |
| Atricure, Inc. | 1 | $99 |
| Akcea Therapeutics, Inc. | 4 | $98 |
| Abbott | 3 | $98 |
| Amarin Pharma, Inc. | 4 | $68 |
| Sanofi-aventis U.S. LLC | 4 | $63 |
| Boehringer Ingelheim | 4 | $56 |
| Regeneron Healthcare Solutions, Inc. | 3 | $39 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Gilead | 2 | $32 |
| Corindus Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$339
- FARXIGA$125
- VYNDAQEL$119
- GENERAL - THERAPIES$113
- Repatha$107
How this compares
$4,255 in reported general payments places this provider in the 65th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Other cardiovascular disease in Pittsburgh
- Stephen ChanPittsburgh$1.2M
- Rewat CholapraneePittsburgh$598K
- George GabrielPittsburgh$584K
- Indu PoornimaPittsburgh$422K
- Brian HenryPittsburgh$269K
- Timothy WongPittsburgh$265K
- Mark GreathousePittsburgh$243K
- Danielle DuffyPhiladelphia$29.5M
- Venkatesh NadarCamp Hill$18.3M
- Hemal GadaWormleysburg$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.